AngioDynamics, Inc. (ANGO) Stock

AngioDynamics, Inc. (ANGO) is a Healthcare stock trading at $12.15 (as of 2026-06-18), with a market capitalization of $462.77M and a trailing P/E of -15.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

AngioDynamics, Inc. designs, manufactures, and sells medical and diagnostic devices used by healthcare professionals for treatment of peripheral vascular disease and vascular access, and in oncology and surgical settings. Its offerings include tissue ablation systems and tract sealant and related catheter and interventional products, used primarily in the United States and internationally.

Valuation — source: SEC EDGAR (first-party)
Price	$12.15
Market Cap	$462.77M
P/E Ratio	-15.9
EV / EBITDA	-37.5
Price / Book	2.88
Price / Sales	1.59
DCF Value (model)	$-4.74
DCF Upside vs Price	-139.0%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$292.50M
Net Margin	-11.6%
Return on Equity	-18.1%
Current Ratio	2.35
Revenue Growth (YoY)	8.9%
EPS Growth (YoY)	72.7%
FCF Growth (YoY)	-49.3%

Financial Health — source: SEC EDGAR
Altman Z-Score	1.87 (grey)

Valuation vs Sector & Industry
Stock P/E	-15.9
Sector P/E (Healthcare)	21.0
Industry P/E (Medical Equipment)	31.7
vs Sector	-176.0%
vs Industry	-150.2%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	BlackRock Fund Advisors ($42.40M)
Institutional Holders Tracked	10
Congressional Trades (recent)	1

Company
Sector	Healthcare
Industry	Medical Equipment
CEO	James C. Clemmer
Employees	748
Country	US
IPO Date	2004-06-01

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.